Sales & Marketing Automating - and optimising - HCP engagement to maximise com... Life sciences marketing has rapidly evolved to mirror that of consumer retail.
News Sanofi, CytoReason expand AI deal into IBD Tech company CytoReason has announced it has signed a multi-year, multimillion dollar deal with Sanofi to deliver artificial intelligence (AI) for drug discovery and development in the fiel
Digital 2023 predictions and challenges in the healthcare business With a new year comes an opportunity for professionals in the healthcare industry to evaluate goals and initiatives for 2023.
Digital The importance of AI literacy in life sciences The promise and value of artificial intelligence (AI) in life sciences are somewhat obscured by the over-generalisation of this technology.
Patients The rise of prescription drug abuse and drug diversion As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased.
Digital AI and the Big Data paradigm – big ambitions in novel drug d... Over the past few decades, data generation has veritably exploded.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
